Year: All Releases2018201720162015201420132012 September 17, 2018 Mersana Announces FDA Lifts Partial Clinical Hold for XMT-1522 PDF Version August 30, 2018 Mersana Therapeutics to Present at Upcoming Investor Conferences PDF Version August 14, 2018 Mersana Therapeutics Announces Second Quarter 2018 Financial Results and Provides Business Updates PDF Version August 8, 2018 Mersana Therapeutics to Present at the Wedbush PacGrow Healthcare Conference PDF Version August 8, 2018 Mersana Therapeutics to Host Conference Call Announcing Second Quarter 2018 Financial Results and Business Updates PDF Version July 19, 2018 Mersana Therapeutics Announces Partial Clinical Hold for XMT-1522 Clinical Trial PDF Version June 4, 2018 Mersana Presents Interim Dose-Escalation Data on XMT-1522 in Select Cancers at ASCO 2018 PDF Version May 31, 2018 Mersana Therapeutics to Present at the Jefferies Global Healthcare Conference PDF Version May 22, 2018 Mersana Therapeutics to Present Interim Phase 1 Data on XMT-1522 at the 2018 American Society of Clinical Oncology Annual Meeting PDF Version May 14, 2018 Mersana Therapeutics Announces First Quarter 2018 Financial Results and Provides Business Updates PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
